57 related articles for article (PubMed ID: 26635150)
1. Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.
Bahlmann J; Brod J; Hubrich W; Cachovan M; Pretschner P
Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():113S-7S. PubMed ID: 26635150
[TBL] [Abstract][Full Text] [Related]
2. Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.
Bahlmann J; Brod J; Hubrich W; Cachovan M; Pretschner P
Br J Clin Pharmacol; 1979; 8(Suppl 2):113S-117S. PubMed ID: 526390
[TBL] [Abstract][Full Text] [Related]
3. [The effect of combined alpha and beta blockade with labetalol on the haemodynamics of stress reaction in hypertensives (author's transl)].
Bahlmann J; Brod J; Hubrich W; Pretschner P
Dtsch Med Wochenschr; 1980 Oct; 105(41):1414-8. PubMed ID: 7449643
[TBL] [Abstract][Full Text] [Related]
4. Immediate effects of labetalol on central, splanchnic-hepatic, and forearm haemodynamics during pleasant emotional stress in hypertensive patients.
Trap-Jensen J; Clausen JP; Hartling OJ; Svendsen TL; Krogsgaard AR
Postgrad Med J; 1980; 56 Suppl 2():37-42. PubMed ID: 7433341
[TBL] [Abstract][Full Text] [Related]
5. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
6. Intravenous labetalol in the emergency treatment of hypertension.
Vidt DG
J Clin Hypertens; 1985 Jun; 1(2):179-86. PubMed ID: 3915322
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological effects of labetalol in man.
Richards DA
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
[TBL] [Abstract][Full Text] [Related]
8. Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
Pedersen EB; Larsen JS
Postgrad Med J; 1980; 56 Suppl 2():27-32. PubMed ID: 7433339
[TBL] [Abstract][Full Text] [Related]
9. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral labetalol on forearm and hepatic circulations in normotensive humans.
Sweeney MO; Cinquegrani M; Liang CS
J Lab Clin Med; 1987 May; 109(5):589-94. PubMed ID: 3572208
[TBL] [Abstract][Full Text] [Related]
11. Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines.
Lechi A; Picotti GB; Covi G; Pomari S; Pedrolli E; Cesura AM; Danti G; Mattioli M
Arzneimittelforschung; 1981; 31(3):524-6. PubMed ID: 7013770
[TBL] [Abstract][Full Text] [Related]
12. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
Zech P; Pozet N; Sassard J; Vincent M
Nouv Presse Med; 1980 Mar; 9(15):1087-90. PubMed ID: 7008020
[TBL] [Abstract][Full Text] [Related]
13. Central versus peripheral blood pressure in malignant hypertension; effects of antihypertensive treatment.
van den Bogaard B; Immink RV; Westerhof BE; van Montfrans GA; van Lieshout JJ; van den Born BJ
Am J Hypertens; 2013 Apr; 26(4):574-9. PubMed ID: 23467212
[TBL] [Abstract][Full Text] [Related]
14. Current status of labetalol, the first alpha- and beta-blocking agent.
Kanto JH
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of labetalol in the dog. Comparative study in the anesthetized open-chest dog and in the conscious dog.
Saito D; Abe Y; Tani H; Kusachi S; Takeda K; Hyodo T; Haraoka S; Nagashima H
Arzneimittelforschung; 1986; 36(1):88-91. PubMed ID: 2869764
[TBL] [Abstract][Full Text] [Related]
16. Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.
Kornerup HJ; Pedersen EB; Pedersen A; Pedersen G; Christensen NJ
Postgrad Med J; 1980; 56 Suppl 2():49-52. PubMed ID: 7001422
[TBL] [Abstract][Full Text] [Related]
17. Labetalol in the treatment of angina pectoris.
Kanto JH
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):166-74. PubMed ID: 2881899
[TBL] [Abstract][Full Text] [Related]
18. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
Martinand A; Lardoux H; Corvol P; Milliez P
Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
[TBL] [Abstract][Full Text] [Related]
19. Family history and pathophysiological mechanisms of primary hypertension. Studies in non-hypertensive young men with positive and negative family histories of hypertension.
Widgren BR
Scand J Urol Nephrol Suppl; 1991; 134():1-75. PubMed ID: 1887213
[TBL] [Abstract][Full Text] [Related]
20. Chronic alpha-1-adrenergic blockade increases sympathoneural but not adrenomedullary activity in patients with essential hypertension.
Jacobs MC; Lenders JW; Willemsen JJ; Thien T
J Hypertens; 1995 Dec; 13(12 Pt 2):1837-41. PubMed ID: 8903663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
